id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1960-0006,FDA,FDA-2019-E-1960,Determination of Regulatory Review Period for Purposes of Patent Extension; LOKELMA,Notice,Determinations,2023-02-08T05:00:00Z,2023,2,2023-02-08T05:00:00Z,2023-04-11T03:59:59Z,2024-02-05T15:16:40Z,2023-02667,0,0,090000648563f05a
FDA-2019-E-1960-0005,FDA,FDA-2019-E-1960,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T17:34:16Z,,0,0,0900006485627359